Shanghai Haohai Biological Technology Co., Ltd.
Simbolis: 6826.HK
HKSE
42.45
HKDRinkos kaina šiandien
15.1027
P/E santykis
0.7575
PEG koeficientas
16.43B
MRK kapitalizacija
- 0.01%
DIV pajamingumas
Shanghai Haohai Biological Technology Co., Ltd. (6826-HK) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2751.1 | 2541.7 | 2907.2 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 11.1 | 6.7 | 6.4 | ||||||||||
balance-sheet.row.net-receivables | 0 | 447.6 | 471.1 | 375.2 | ||||||||||
balance-sheet.row.inventory | 0 | 526.2 | 485.2 | 354.8 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 25.2 | 34.1 | 69.6 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 3750.1 | 3532.1 | 3712.6 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1553 | 1409.6 | 1248.9 | ||||||||||
balance-sheet.row.goodwill | 0 | 413 | 411.2 | 406.9 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 729.1 | 783.5 | 783.1 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1142.1 | 1194.7 | 1190 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 596 | 664.7 | 619 | ||||||||||
balance-sheet.row.tax-assets | 0 | 53.1 | 59.3 | 49.4 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | 11.1 | 32 | 130.5 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 3355.4 | 3360.3 | 3237.8 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 7105.5 | 6892.4 | 6950.4 | ||||||||||
balance-sheet.row.account-payables | 0 | 55.1 | 54.5 | 46.3 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 216.6 | 34.4 | 66 | ||||||||||
balance-sheet.row.tax-payables | 0 | 58.4 | 52.1 | 17.8 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 191.3 | 83.9 | 39.5 | ||||||||||
Deferred Revenue Non Current | 0 | 13.6 | 5.5 | 9.4 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 444.2 | 422.4 | 375 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 372.3 | 478.7 | 402.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 54.2 | 61.3 | 46.7 | ||||||||||
balance-sheet.row.total-liab | 0 | 1088.2 | 990 | 890.1 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 71.7 | 47 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 171.5 | 174.1 | 175.8 | ||||||||||
balance-sheet.row.retained-earnings | 0 | 2728.6 | 2369.5 | 2309.7 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -71.7 | -47 | 47.9 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2750 | 2971 | 3180 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5650.1 | 5514.6 | 5713.5 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7105.5 | 6892.4 | 6950.4 | ||||||||||
balance-sheet.row.minority-interest | 0 | 367.2 | 387.8 | 346.8 | ||||||||||
balance-sheet.row.total-equity | 0 | 6017.3 | 5902.4 | 6060.3 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 607.1 | 671.4 | 625.3 | ||||||||||
balance-sheet.row.total-debt | 0 | 407.9 | 118.3 | 105.5 | ||||||||||
balance-sheet.row.net-debt | 0 | -2332.1 | -2423.5 | -2795.3 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 508.3 | 235.7 | 382.6 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 197.9 | 204.2 | 162.8 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | -81.6 | 0 | 0 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 14.3 | 30.2 | 0 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 73.2 | -183.5 | 23.9 | ||||||||||
cash-flows.row.account-receivables | 0 | 0 | -52.3 | -41.9 | ||||||||||
cash-flows.row.inventory | 0 | -48.4 | -138.9 | -28.6 | ||||||||||
cash-flows.row.account-payables | 0 | 0 | 52.3 | 41.9 | ||||||||||
cash-flows.row.other-working-capital | 0 | 121.6 | -44.6 | 52.6 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | -77.6 | -55.4 | -227.1 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -267.2 | -317.1 | -272.1 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 1.6 | 14.7 | -83.3 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | -204.2 | -528.8 | -696.6 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 14.6 | 9.1 | 749.3 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 78.6 | 140.4 | 154.6 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -376.6 | -681.8 | -148.1 | ||||||||||
cash-flows.row.debt-repayment | 0 | -16.4 | -47.9 | -95.5 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 73.7 | 0 | -4 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | -270 | -147.7 | -44.9 | ||||||||||
cash-flows.row.dividends-paid | 0 | -68.5 | -121.9 | -87.9 | ||||||||||
cash-flows.row.other-financing-activites | 0 | -245.7 | 29.1 | 1.1 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -257.7 | -288.4 | -231.3 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 10 | 14.2 | -6.9 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | 10.1 | -724.7 | -44 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 569.3 | 559.2 | 1283.9 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 559.2 | 1283.9 | 1327.9 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | 634.5 | 231.3 | 342.3 | ||||||||||
cash-flows.row.capital-expenditure | 0 | -267.2 | -317.1 | -272.1 | ||||||||||
cash-flows.row.free-cash-flow | 0 | 367.2 | -85.9 | 70.2 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 2634.9 | 2103.4 | 1750.1 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 781.4 | 656.5 | 490.4 | ||||||||||
income-statement-row.row.gross-profit | 0 | 1853.5 | 1446.9 | 1259.7 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | -4 | -40.3 | -33.9 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 1415.1 | 1226.8 | 1032.2 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2196.5 | 1883.3 | 1522.5 | ||||||||||
income-statement-row.row.interest-income | 0 | 77.7 | 87.9 | 98.2 | ||||||||||
income-statement-row.row.interest-expense | 0 | 7.3 | 7.6 | 5 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -4.7 | -22.9 | -1.8 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | -4 | -40.3 | -33.9 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | -4.7 | -22.9 | -1.8 | ||||||||||
income-statement-row.row.interest-expense | 0 | 7.3 | 7.6 | 5 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 197.9 | 204.2 | 162.8 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | 513 | 258.7 | 384.4 | ||||||||||
income-statement-row.row.income-before-tax | 0 | 508.3 | 235.7 | 382.6 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 96 | 45.4 | 35.4 | ||||||||||
income-statement-row.row.net-income | 0 | 416.1 | 180.5 | 352.2 |
Dažnai užduodami klausimai
Kas yra Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) bendras turtas?
Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) bendras turtas yra 7105497000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.698.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 1.049.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.162.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.177.
Kas yra Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 416121000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 407949000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 1415132000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.